Guideline-Directed Medical Therapy—Secondary Prevention Checklist

The rapid evolution of medical technology and knowledge in cardiovascular disease management presents a challenge to health care providers. The Guideline-Directed Medical Therapy—Secondary Prevention Checklist (SPC) has been formulated to address the practical aspects of the clinical encounter, notably time constraints, the nuances of care, current gaps in guideline knowledge, patient adherence, and acceptance of therapy (the Secondary Prevention Checklist is available as Supplemental Appendix S1). The SPC, which has been developed according to evidence-based recommendations to optimize management of vascular events, encompasses 3 stages of patient care: the first post acute coronary syndromes (ACS)/percutaneous coronary intervention (PCI) visit, the 3-month follow-up, and the 1-year post-event visit. Standardized checklists, which are on the basis of current secondary prevention guidelines, offer a practical tool to bridge the gap between clinical guidelines and daily practice to maintain consistency in patient care, particularly in settings where care involves multiple providers. By offering evidence-based steps for practitioners, checklists can potentially reduce variability in care, contributing to improved patient outcomes including decreased hospital readmissions, and reduced complication rates. Moreover, checklists can offer a systematic approach to treatment, providing a structured framework for interventions at different stages of disease management. The SPC addresses a significant need, namely low rates of guideline adherence among providers. Despite comprehensive guidelines issued by national and international cardiovascular medicine societies, there remains a gap between these guidelines and their implementation in clinical practice. This discrepancy is often due to a lack of awareness among health care providers of the most recent updates or challenges faced because of the complexities inherent in clinical scenarios. Likewise, time constraints and demanding clinical environments can impede the delivery of care at the guideline-recommended level. This checklist is intended to support providers to overcome these challenges by translating complex guidelines into clear and actionable steps. The SPC is focused on ACS and includes considerations for elective PCI. It has been designed for use by all health care professionals involved in patient care starting at the first clinical follow-up visit post discharge, ensuring that it is used at the most critical junctures to maximize its effect on patient outcomes. By using the checklist, health care providers can ensure that their care aligns with the best practices as outlined in Canadian and international cardiovascular secondary prevention guidelines. The SPC is intended to assist practitioners at 3 key stages of patient management after ACS or PCI (Fig. 1), as outlined in the following sections. This section of the checklist focuses on establishing a baseline for care, ensuring that all immediate post-hospitalization therapies are initiated. Key components include the initiation of dual antiplatelet therapy (DAPT), renin angiotensin aldosterone inhibition, management of comorbid conditions, consideration for lipid-lowering therapies, lifestyle interventions, and referral for cardiac rehabilitation. The second stage of the SPC evaluates the patient's adherence to the prescribed therapies, the effectiveness and tolerability of the interventions, and the patient's progress in lifestyle changes. This stage is important for supporting the initial therapies and making adjustments on the basis of the patient's response and any new evidence that might affect treatment. The final stage of the checklist is aimed at long-term management and stability, transitioning from acute care to chronic disease management. It is used to reassesses pharmacologic therapies, lifestyle modifications, and disease progression, and allows for adjustment of treatments to maintain optimal health outcomes. The checklist is consistent with the latest guidelines from Canadian, American, and European cardiovascular societies, ensuring that the recommendations are grounded in up-to-date, peer-reviewed research and expert consensus.1Fihn S.D. Gardin J.M. Abrams J. et al.2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.Circulation. 2012; 126: e354-e471Google Scholar, 2Mancini G.J. Gosselin G. Chow B. et al.Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart disease.Can J Cardiol. 2014; 30: 837-849Google Scholar, 3Pearson G.J. Thanassoulis G. Anderson T.J. et al.2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults.Can J Cardiol. 2021; 37: 1129-1150Google Scholar, 4Visseren F.L. Mach F. Smulders Y. et al.2021 ESC guidelines on cardiovascular disease prevention in clinical practice developed by the task force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies with the special contribution of the European Association of Preventive Cardiology (EAPC).Eur Heart J. 2021; 42: 3227-3337Google Scholar These tools are designed to be used at the point of care, providing quick-reference guides that are practical and formed on the basis of rigourous scientific evidence. The initial post-ACS/PCI visit checklist establishes the foundation for secondary prevention. Immediately after hospital discharge, it engages the practitioner in a review and initiation of essential interventions necessary for effective long-term management. The checklist underscores the importance of immediate referral to either medically supervised or physician-directed home-based cardiac rehabilitation programs. Early engagement in these programs is critical, because it has been shown to improve physical fitness, alleviate cardiac symptoms, and enhance patient self-management capabilities, contributing positively to recovery outcomes.1Fihn S.D. Gardin J.M. Abrams J. et al.2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.Circulation. 2012; 126: e354-e471Google Scholar A key component of this checklist is the consideration of DAPT, usually recommended for a minimum of 1 year. The application of DAPT is adjusted on the basis of a personalized assessment of bleeding and thrombotic risks, ensuring that the therapy is tailored to individual patient needs.5Mehta S.R. Bainey K.R. Cantor W.J. et al.2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology focused update of the guidelines for the use of antiplatelet therapy.Can J Cardiol. 2018; 34: 214-233Google Scholar Furthermore, the protocol calls for the initiation of high-potency statins and renin angiotensin aldosterone system inhibitors in alignment with contemporary guidelines.3Pearson G.J. Thanassoulis G. Anderson T.J. et al.2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults.Can J Cardiol. 2021; 37: 1129-1150Google Scholar,4Visseren F.L. Mach F. Smulders Y. et al.2021 ESC guidelines on cardiovascular disease prevention in clinical practice developed by the task force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies with the special contribution of the European Association of Preventive Cardiology (EAPC).Eur Heart J. 2021; 42: 3227-3337Google Scholar The checklist provides comprehensive guidance on lifestyle modifications, including smoking cessation, dietary changes, and physical activity recommendations. These interventions are customized according to the patient's abilities, preferences, and specific health risks, aiming to maximize compliance and therapeutic effectiveness. Critical to the checklist is the detailed planning of follow-up assessments. These evaluations are vital for tracking adherence to prescribed therapies and for adjusting treatment plans as necessary, on the basis of patient progress and emerging clinical evidence. At 3 months post ACS/PCI, the follow-up checklist prompts providers to assess and adjust the therapeutic interventions initiated during the initial post-event visit. This period is essential for several evaluative and adaptive processes in patient care. The checklist at this stage includes a systematic assessment of patient adherence to prescribed cardiac rehabilitation programs and pharmacological treatments. It specifically monitors the continuity of DAPT, statin, and other medication adherence, alongside lifestyle modifications such as smoking cessation and dietary adjustments. These evaluations help determine the effectiveness of the initial interventions and identify areas where additional support might be required.4Visseren F.L. Mach F. Smulders Y. et al.2021 ESC guidelines on cardiovascular disease prevention in clinical practice developed by the task force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies with the special contribution of the European Association of Preventive Cardiology (EAPC).Eur Heart J. 2021; 42: 3227-3337Google Scholar Modifications to therapy are considered on the basis of recent lipid profile reassessments and the patient's tolerance to all prescribed medications. This might involve altering the dosage or type of lipid-lowering agents, renin angiotensin aldosterone system inhibitors, and antiplatelet drugs to better suit the patient's current health status and to mitigate any adverse effects.3Pearson G.J. Thanassoulis G. Anderson T.J. et al.2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults.Can J Cardiol. 2021; 37: 1129-1150Google Scholar This phase includes a continuous evaluation of cardiovascular risk factors to dynamically adjust the treatment plans as needed. This ongoing risk assessment is necessary for addressing new or evolving issues and for facilitating interventions. The follow-up checklist is used to confirm the implementation of initial interventions and evaluate their effectiveness. Adjustments are made on the basis of individual patient responses and the evolving body of clinical evidence. This approach maintains the rigour and precision of the secondary prevention strategy, ensuring that patient care remains dynamic and responsive to the latest research and guidelines. By systematically applying this checklist, health care providers can enhance the quality and continuity of care, and thus promote better health outcomes through individualized and evidence-based interventions. This structured reassessment at the 3-month mark plays an integral role in the ongoing management of patients post ACS/PCI, supporting a proactive and informed approach to cardiovascular health care. The 1-year post-event visit signifies a key transition in the patient's care trajectory, moving from acute care management to the ongoing approach to stable cardiovascular disease. This visit involves a comprehensive assessment, forming the basis for long-term therapeutic strategies and disease monitoring. At this stage, providers evaluate the continuation, cessation, or modification of key medications such as antiplatelet and statin medications. These decisions are informed by the latest clinical guidelines and tailored to the individual's specific health conditions, including considerations of bleeding risks and ongoing ischemic risks.5Mehta S.R. Bainey K.R. Cantor W.J. et al.2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology focused update of the guidelines for the use of antiplatelet therapy.Can J Cardiol. 2018; 34: 214-233Google Scholar Adjustments to medication are also influenced by patient-reported side effects and preferences, reflecting a patient-centred approach to pharmacotherapy. This part of the checklist is used to assess the patient's adherence to lifestyle modifications and the effect of such changes on their health. It is used to examine the sustainability of dietary changes, cessation of smoking, and physical activity regimes. Furthermore, the effectiveness of cardiac rehabilitation programs in sustaining or improving cardiovascular health is evaluated. Patients are encouraged to persist with or modify their lifestyle changes on the basis of their current health status and practical considerations. This involves a detailed reassessment of cardiovascular risks and overall health status to adapt effective chronic disease management strategies. Such reevaluation encompasses monitoring for new or exacerbated symptoms, changes in physical health, and psychological factors that might influence health and treatment adherence. The goal is to adjust the management plan to reflect the patient's current health conditions and the latest scientific evidence, thus optimizing outcomes in preventing disease recurrence. This checklist highlights the planning of future health care interactions and screenings on the basis of the reevaluation of the patient's health. Such planning is important for the early detection and management of potential complications, facilitating continuous monitoring and timely medical intervention. The SPC represents a pivotal advancement in cardiovascular care. By systematically applying the guideline-directed medical therapy SPC, practitioners can ensure comprehensive and consistent care that is aligned with the highest standards of clinical practice for cardiovascular care. The implementation of this tool not only supports practitioners in providing guideline-level care, but also might streamline patient management and contribute to improved patient outcomes.